Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics
2018年7月30日 - 6:30PM
Sunnyvale, July 30, 2018 (GLOBE NEWSWIRE) -- July 30, 2018 -
Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences
and personalized medicine company, signs allergy testing contracts
with a consortium of medical clinics nationwide. The network
comprises 178 medical clinics in 29 of the 48 contiguous United
States including the Northeast, Southeast, Midwest, South,
Southwest, Pacific and Pacific Northwest regions, with single
clinics staffing up to 70 physicians. The clinics are using
Arrayit allergy testing services to assist physicians in diagnosing
and treating allergy and asthma across a wide range of medical
specialties and focus areas including anti-aging, back pain and
sciatica, chiropractic care, dermatology, digestive health, ear
nose and throat (ENT), family medicine, gastroenterology, health
and beauty, immunology, integrative medicine, internal medicine,
obesity, obstetrics and gynecology (OB-GYN), pain relief,
pediatrics, personalized medicine, preventative medicine, primary
care, rehabilitation, sinus, spinal care, urgent care, weight loss,
wellness and women’s health.
Arrayit recently established a nationwide sales network of 1,700
sales professionals to sell and distribute the company’s finger
stick microarray tests to medical clinics and retail chains,
completed allergy pilot testing with one the nation’s largest
chains of retail stores, met with top officials at the United
States Food and Drug Administration (FDA) to discuss FDA approval
of a major product line, and reported the sale of clinical
instrumentation to the FDA. Arrayit microarray tests
conveniently use a few drops of patient blood collected on a blood
card to assist doctors in identifying and treating food
intolerance, allergy and asthma, and pipeline indications for more
serious conditions such as ovarian cancer and Parkinson’s
Disease. Doctors can use allergy test results as quantitative
tools to inform decisions regarding allergy medicines,
immunotherapy, food elimination and lifestyle changes.
Arrayit CEO Rene Schena states, “We are pleased to announce
allergy testing contracts with a medical clinics consortium
comprising a remarkable breadth and depth of medical specialties
and focus areas. Arrayit’s accurate and non-invasive allergy
testing services can provide a healthcare cornerstone by empowering
physicians to better treat and manage allergy and asthma and
mitigate the acute and chronic consequences of these
conditions.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please visit www.arrayit.com for
more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 10 2024 まで 11 2024
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 11 2023 まで 11 2024
